Ebola drug in Guinea helps some, stirs debate on broader use

February 23, 2015 11:01 PM

18 0

DAKAR (Reuters) - A Japanese anti-Ebola drug being tested in Guinea should be made available across West Africa after initial trials showed it halved mortality rates in some patients, the medical charity administering it said.

Alliance for International Medical Action (ALIMA), which ran the trials of favipiravir in Guinea, said mortality rates fell from 30 to 15 percent in patients with a low to moderate Ebola count but was not effective on those with a high level of the virus.

Read more

To category page